Everardo, P.-G. et al. 2021. Bioavailability assessment of fexofenadine and montelukast in a fixed-dose combination tablet versus the components administered simultaneously. Allergologia et Immunopathologia. 49, 4 (Mar. 2021), 15–25. DOI:https://doi.org/10.15586/aei.v49i4.89.